00239.HK
Pak Fah Yeow International Limited
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · HK
HKD 2.50
−0.79%Margins
Gross margin
74.8%
EBITDA margin
56.8%
EBIT margin
51.1%
Net margin
40.5%
FCF margin
26.8%
23.1%
Return on equity
19.3%
Return on assets
28.9%
Return on invested capital
0.49x
Asset turnover
HKD 112.8M
Cash from operations
HKD 1.28
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026